Topical Refrigerant Spray for IVs: Patient/Provider Responses - Prospective, Double-blind, Randomized Study

Painful procedures are common. Patients prefer analgesia for painful procedures. Studies indicate that use of a topical refrigerant spray (TRS) prior to needlestick procedures decreases needlestick pain. TRS is easy to apply, inexpensive, has fast onset, and avoids needlestick pain and anxiety, and...

Full description

Saved in:
Bibliographic Details
Published in:Western journal of nursing research 2021-08, Vol.43 (8), p.762-769
Main Authors: Barbour, Tracy, O’Keefe, Sharon, Mace, Sharon E.
Format: Article
Language:English
Subjects:
Acceptance
Administration, Topical
Adult
Analgesia
Anesthetics, Local - therapeutic use
Double-Blind Method
Double-blind studies
Health care
Humans
Injuries
Medical personnel
Needles
Needlestick injuries
Pain
Pain - drug therapy
Pain Measurement
Patient satisfaction
Patients
Prospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Painful procedures are common. Patients prefer analgesia for painful procedures. Studies indicate that use of a topical refrigerant spray (TRS) prior to needlestick procedures decreases needlestick pain. TRS is easy to apply, inexpensive, has fast onset, and avoids needlestick pain and anxiety, and needlestick injury risk. Patient and health care provider (HCP) acceptance of any technique is essential before it is adopted. This study evaluated the decrease in pain with TRS and the patient and HCP satisfaction and acceptance of TRS for peripheral intravenous (PIV) placement. Adults (N = 300) randomized to placebo or TRS and HCPs (N = 300) placing PIVs answered questionnaires. Patients had significantly less pain than with prior PIVs, and were satisfied with and would use TRS in the future (P < 0.001). HCP felt that patients had significantly (P < 0.001) less pain with TRS than the placebo, and were satisfied with the TRS, and would use TRS in the future. Registered at Clinicaltrials.gov NCT01670487
ISSN:0193-9459
1552-8456
DOI:10.1177/0193945920976061